HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China · Delayed Price · Currency is CNY 2.930
-0.110 (-3.62%)
Nov 13, 2026, 3:04 PM CST
SHE:002437 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 492.47 | 396.4 | 481.96 | 711.28 | 1,238 | 1,496 |
Trading Asset Securities | 627.47 | 533.66 | 30 | - | 50.56 | - |
Cash & Short-Term Investments | 1,120 | 930.06 | 511.96 | 711.28 | 1,288 | 1,496 |
Cash Growth | 34.93% | 81.66% | -28.02% | -44.79% | -13.87% | 67.04% |
Accounts Receivable | 128.78 | 128.38 | 128.62 | 207.67 | 236.82 | 235.59 |
Other Receivables | 24.98 | 23.73 | 18.87 | 26.65 | 36.53 | 82.85 |
Receivables | 153.76 | 152.11 | 147.49 | 234.32 | 273.35 | 318.45 |
Inventory | 196.88 | 205.88 | 188.67 | 190.67 | 214.14 | 352.09 |
Other Current Assets | 58.37 | 30.81 | 29.06 | 18.19 | 40.4 | 34.17 |
Total Current Assets | 1,529 | 1,319 | 877.19 | 1,154 | 1,816 | 2,200 |
Property, Plant & Equipment | 937.01 | 985.51 | 1,029 | 1,059 | 1,119 | 1,235 |
Long-Term Investments | 344.46 | 237.51 | 277.56 | 298.23 | 458.25 | 498.33 |
Goodwill | 369.03 | 369.03 | 369.03 | 369.03 | 369.03 | 411.16 |
Other Intangible Assets | 138.45 | 162.98 | 166.66 | 191.3 | 221.18 | 290.34 |
Long-Term Deferred Tax Assets | 15.41 | 16.53 | 16.46 | 21.01 | 33.77 | 24.19 |
Long-Term Deferred Charges | 8.57 | 7.97 | 14.45 | 8.23 | 9.7 | 17.21 |
Other Long-Term Assets | 36.84 | 36.2 | 74.73 | 51.58 | 46.62 | 18.21 |
Total Assets | 3,379 | 3,135 | 2,825 | 3,152 | 4,074 | 4,695 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 74.32 | 65.13 | 60.45 | 69.88 | 75.48 | 270.49 |
Accrued Expenses | 7.47 | 341.62 | 395.46 | 109.41 | 516.94 | 527.16 |
Short-Term Debt | 105.82 | 90.06 | - | 675.69 | 1,455 | 1,558 |
Current Portion of Leases | 0.99 | 1.38 | 1.33 | - | - | - |
Current Income Taxes Payable | 32.89 | 7.71 | 10.23 | 9.67 | 10.26 | 9.33 |
Current Unearned Revenue | 27.2 | 44.9 | 44.2 | 50.03 | 83.17 | 86.98 |
Other Current Liabilities | 524.25 | 247.05 | 311.37 | 496.47 | 195.49 | 226.24 |
Total Current Liabilities | 772.94 | 797.85 | 823.03 | 1,411 | 2,336 | 2,678 |
Long-Term Leases | - | 0.57 | 1.95 | - | - | - |
Long-Term Unearned Revenue | 11.7 | 12.32 | 12.92 | 17.87 | 21.43 | 24.53 |
Long-Term Deferred Tax Liabilities | 12.8 | 13.19 | 13.28 | 12.12 | 12.87 | 12.55 |
Other Long-Term Liabilities | 1.05 | 1.08 | 1.08 | 1.08 | 0.03 | 0.82 |
Total Liabilities | 798.49 | 825 | 852.26 | 1,442 | 2,371 | 2,716 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 2,230 | 2,232 | 2,280 | 2,198 | 2,198 | 2,198 |
Additional Paid-In Capital | 161.3 | 413.29 | 456.81 | 380.47 | 471.13 | 448.21 |
Retained Earnings | 198.59 | -304.54 | -680.75 | -913.51 | -1,034 | -742.51 |
Treasury Stock | -22.39 | -42.93 | -102.03 | - | - | - |
Comprehensive Income & Other | -6.6 | -4.19 | -3.09 | -3.32 | -4.17 | -9.61 |
Total Common Equity | 2,561 | 2,294 | 1,951 | 1,662 | 1,631 | 1,894 |
Minority Interest | 19.48 | 15.9 | 22.15 | 48.46 | 72.3 | 84.7 |
Shareholders' Equity | 2,580 | 2,310 | 1,973 | 1,710 | 1,704 | 1,979 |
Total Liabilities & Equity | 3,379 | 3,135 | 2,825 | 3,152 | 4,074 | 4,695 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 106.81 | 92.01 | 3.28 | 675.69 | 1,455 | 1,558 |
Net Cash (Debt) | 1,013 | 838.05 | 508.68 | 35.59 | -166.67 | -62.42 |
Net Cash Growth | 33.72% | 64.75% | 1329.47% | - | - | - |
Net Cash Per Share | 0.46 | 0.37 | 0.22 | 0.02 | -0.08 | -0.03 |
Filing Date Shares Outstanding | 2,230 | 2,232 | 2,280 | 2,198 | 2,198 | 2,198 |
Total Common Shares Outstanding | 2,230 | 2,232 | 2,280 | 2,198 | 2,198 | 2,198 |
Working Capital | 756.02 | 521 | 54.16 | -256.7 | -520.11 | -477.9 |
Book Value Per Share | 1.15 | 1.03 | 0.86 | 0.76 | 0.74 | 0.86 |
Tangible Book Value | 2,053 | 1,762 | 1,415 | 1,101 | 1,041 | 1,193 |
Tangible Book Value Per Share | 0.92 | 0.79 | 0.62 | 0.50 | 0.47 | 0.54 |
Buildings | - | 1,238 | 1,233 | 1,232 | 1,239 | 1,310 |
Machinery | - | 794.32 | 797.43 | 807.63 | 803.46 | 801.97 |
Construction In Progress | - | 1.37 | 1.89 | 3.05 | 12.89 | 1.8 |